CHMP-CAT - D80-210 Overview to final EPAR - Rev 07.25 Revamp

Human medicines European public assessment report (EPAR): Omnitrope, somatropin, Date of authorisation: 12/04/2006, Revision: 23, Status: Authorised

PSUSA/00002013/202412

PSUSA/00002024/202410

PSUSA/00000997/202410

Declaration of interest form: Public call for Scientific Advisory Group on Immune and Inflammatory Diseases

Public call for expression of interest for experts to become members of the European Medicines Agency's Scientific Advisory Group on Immune and Inflammatory Diseases

Recommendations on eligibility to PRIME scheme adopted at the CHMP meeting of 21-24 July 2025

List of medicines currently in PRIME scheme

Human medicines European public assessment report (EPAR): Kalydeco, ivacaftor, Date of authorisation: 23/07/2012, Revision: 46, Status: Authorised